Drugs / TIVf
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02256488 Comparator | Sep → Dec 2014 | — | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIVf | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02256488 ↗ |
| Modality | Vaccine | “egg based trivalent subunit influenza vaccine (TIVf)” NCT02256488 ↗ |
| Route | Intramuscular | “Single IM administration dose of 0.5 mL of TIVf” NCT02256488 ↗ |